Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $797.89 million. The enterprise value is $923.44 million.
| Market Cap | 797.89M |
| Enterprise Value | 923.44M |
Important Dates
The last earnings date was Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | Nov 30, 2026 |
Share Statistics
MLAB has 5.62 million shares outstanding. The number of shares has increased by 3.52% in one year.
| Current Share Class | 5.62M |
| Shares Outstanding | 5.62M |
| Shares Change (YoY) | +3.52% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 3.06% |
| Owned by Institutions (%) | 92.50% |
| Float | 4.97M |
Valuation Ratios
The trailing PE ratio is 120.16 and the forward PE ratio is 48.95.
| PE Ratio | 120.16 |
| Forward PE | 48.95 |
| PS Ratio | 3.17 |
| Forward PS | 3.07 |
| PB Ratio | 3.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.10 |
| P/OCF Ratio | 15.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.88, with an EV/FCF ratio of 18.64.
| EV / Earnings | 138.29 |
| EV / Sales | 3.67 |
| EV / EBITDA | 18.88 |
| EV / EBIT | 35.26 |
| EV / FCF | 18.64 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.90 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 2.64 |
| Debt / FCF | 3.02 |
| Interest Coverage | 2.58 |
Financial Efficiency
Return on equity (ROE) is 3.57% and return on invested capital (ROIC) is 4.08%.
| Return on Equity (ROE) | 3.57% |
| Return on Assets (ROA) | 3.90% |
| Return on Invested Capital (ROIC) | 4.08% |
| Return on Capital Employed (ROCE) | 7.34% |
| Weighted Average Cost of Capital (WACC) | 9.12% |
| Revenue Per Employee | $350,522 |
| Profits Per Employee | $9,296 |
| Employee Count | 717 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 3.26 |
Taxes
In the past 12 months, MLAB has paid $6.73 million in taxes.
| Income Tax | 6.73M |
| Effective Tax Rate | 50.22% |
Stock Price Statistics
The stock price has increased by +71.83% in the last 52 weeks. The beta is 1.08, so MLAB's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +71.83% |
| 50-Day Moving Average | 128.76 |
| 200-Day Moving Average | 105.92 |
| Relative Strength Index (RSI) | 62.87 |
| Average Volume (20 Days) | 97,867 |
Short Selling Information
The latest short interest is 390,561, so 6.95% of the outstanding shares have been sold short.
| Short Interest | 390,561 |
| Short Previous Month | 447,048 |
| Short % of Shares Out | 6.95% |
| Short % of Float | 7.86% |
| Short Ratio (days to cover) | 3.34 |
Income Statement
In the last 12 months, MLAB had revenue of $251.32 million and earned $6.67 million in profits. Earnings per share was $1.18.
| Revenue | 251.32M |
| Gross Profit | 162.89M |
| Operating Income | 26.14M |
| Pretax Income | 13.39M |
| Net Income | 6.67M |
| EBITDA | 48.81M |
| EBIT | 26.14M |
| Earnings Per Share (EPS) | $1.18 |
Balance Sheet
The company has $23.95 million in cash and $149.50 million in debt, with a net cash position of -$125.56 million or -$22.34 per share.
| Cash & Cash Equivalents | 23.95M |
| Total Debt | 149.50M |
| Net Cash | -125.56M |
| Net Cash Per Share | -$22.34 |
| Equity (Book Value) | 194.60M |
| Book Value Per Share | 34.66 |
| Working Capital | 46.67M |
Cash Flow
In the last 12 months, operating cash flow was $51.55 million and capital expenditures -$2.10 million, giving a free cash flow of $49.45 million.
| Operating Cash Flow | 51.55M |
| Capital Expenditures | -2.10M |
| Depreciation & Amortization | 22.67M |
| Net Borrowing | -43.44M |
| Free Cash Flow | 49.45M |
| FCF Per Share | $8.80 |
Margins
Gross margin is 64.81%, with operating and profit margins of 10.40% and 2.65%.
| Gross Margin | 64.81% |
| Operating Margin | 10.40% |
| Pretax Margin | 5.33% |
| Profit Margin | 2.65% |
| EBITDA Margin | 19.42% |
| EBIT Margin | 10.40% |
| FCF Margin | 19.68% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.45%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.45% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 54.17% |
| FCF Payout Ratio | 7.27% |
| Buyback Yield | -3.52% |
| Shareholder Yield | -3.05% |
| Earnings Yield | 0.83% |
| FCF Yield | 6.21% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of 1.81 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 7 |